AcelRx Pharmaceuticals, Inc. (ACRX)
DSUVIA FDA Approval and AcelRx Third Quarter 2018 Conference Call
November 05, 2018 08:30 AM ET
Executives
John Saia - General Counsel
Vince Angotti - CEO
Dr. Pam Palmer - Chief Medical Officer
Kimberley Gaumer - VP, Regulatory Affairs and Quality
Raffi Asadorian - CFO
Analysts
Randall Stanicky - RBC Capital Markets
Ed Arce - H.C. Wainwright & Co.
Brandon Folkes - Cantor Fitzgerald
Michael Higgins - Ladenburg Thalmann
David Buck - B.Riley FBR
Leland Gershell - Oppenheimer and Company
Presentation
Operator
Welcome to the DSUVIA FDA Approval and AcelRx Third